CCL18 and lung carcinoma: Meanwhile, we found that treatment with DHA and EPA robustly reduced CCL18 expression in A549 and 95D lung cancer cells, whereas the inhibitory effect of DHA was also more pronounced than that of EPA (Fig. 2C–E).